JAGSON PHAR Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JAGSON PHAR Quarterly Results    (JSPH)

Here are the latest quarterly results of JAGSON PHAR. For more details, see the JAGSON PHAR financial fact sheet and JAGSON PHAR share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

JAGSON PHAR Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-19
*
3
Sep-19
*
3
Dec-19
*
3
Mar-20
*
3
Jun-20
*
3
Sep-20
*
3
Dec-20
*
3
Mar-21
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m452418420571317564571428 
Other income Rs m747584527 
Turnover Rs m459423427576324568576455 
Expenses Rs m430393394506290515506377 
Gross profit Rs m2225266526486551 
Depreciation Rs m33333333 
Interest Rs m11111111 
Profit before tax Rs m2525296630496674 
Tax Rs m55612581223 
Profit after tax Rs m2020235425405451 
Gross profit margin %4.96.06.111.48.48.611.411.9 
Effective tax rate %20.020.020.017.816.717.517.830.9 
Net profit margin %4.44.95.49.58.07.19.511.9 
Diluted EPS Rs 0.8 0.8 0.9 2.1 1.0 1.5 2.1 1.9  
Diluted EPS (TTM) Rs NA NA 3.5 4.5 4.7 5.4 6.6 6.5  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Accord Fintech, Equitymaster

More Pharmaceuticals Company Quarterly Results:   SHREE GANESH REMEDIES   PIRAMAL ENTERPRISES  KOPRAN.  TORRENT PHARMA  PFIZER  

Compare JAGSON PHAR With:   SHREE GANESH REMEDIES   PIRAMAL ENTERPRISES  KOPRAN.  TORRENT PHARMA  PFIZER  



Today's Market

Sensex Ends 209 Points Higher; Hindalco and Tata Steel Among Top Nifty Gainers(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Views on news

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

KIMS Shares Make Strong Debut Listing at a 22% Premium (Views On News)

Jun 28, 2021

KIMS shares pare gains after making a strong debut on the exchanges.

More Views on News

Most Popular

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

These Are the Best Stocks to Own (Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

4 Point Checklist to Invest in Crorepati IPOs (Profit Hunter)

Jul 16, 2021

This is how you should go about investing in big ticket IPOs.

Cash the Crash in Gas Prices (Fast Profits Daily)

Jul 21, 2021

Get ready to profit from the coming crash in the price of natural gas.

Electric 2-Wheelers: The Megatrend has Begun (Profit Hunter)

Jul 20, 2021

The shift to electric 2-wheelers will be faster than expected.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JAGSON PHAR SHARE PRICE


Jul 29, 2021 (Close)

TRACK JAGSON PHAR

  • Track your investment in JAGSON PHAR with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JAGSON PHAR

JAGSON PHAR - ZENOTECH LABS COMPARISON

COMPARE JAGSON PHAR WITH

MARKET STATS